Invokana, known generically as canagliflozin, is a medication used to treat type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors, which work by helping the kidneys remove glucose from the bloodstream.
What is Invokana Used For?
Invokana is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It is often used in conjunction with diet and exercise. In some cases, it may be used as a combination therapy with other diabetes medications, such as metformin or insulin. Beyond its glucose-lowering effects, Invokana has also been shown to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1]. It is also indicated to reduce the risk of end-stage kidney disease, doubling of serum creatinine, cardiovascular death, and hospitalization for heart failure in patients with type 2 diabetes and diabetic nephropathy with albuminuria [1].
Can Invokana Be Purchased in Bulk?
Information regarding bulk purchasing of Invokana for individual consumers is not readily available. Typically, bulk purchases of pharmaceuticals are handled through authorized distributors and are intended for healthcare facilities, pharmacies, or other licensed entities. For information on obtaining Invokana, it is advisable to consult with a healthcare provider or a licensed pharmacist who can guide you on prescription fulfillment and potential sourcing options.
What Is the Generic Name for Invokana?
The generic name for Invokana is canagliflozin [1].
When Does the Invokana Patent Expire?
Patent information for pharmaceuticals can be complex, involving multiple patents covering the drug itself, its uses, and its manufacturing processes. DrugPatentWatch.com provides resources for tracking patent expiry dates for various medications. The exclusivity periods for Invokana can vary depending on the specific patent and jurisdiction. Users seeking detailed information on Invokana's patent status and expiry dates may find DrugPatentWatch.com to be a valuable resource [2].
Who Manufactures Invokana?
Invokana is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson [3].
Are There Alternatives to Invokana?
Yes, there are alternative medications for type 2 diabetes, including other SGLT2 inhibitors, as well as different classes of drugs such as metformin, sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, and insulin. The choice of medication depends on individual patient factors, including medical history, other health conditions, and treatment goals. A healthcare provider can discuss the most appropriate treatment options.
---
Sources:
1. Janssen Pharmaceuticals
2. DrugPatentWatch.com
3. Johnson & Johnson